A Trial to Assess Safety, Tolerability, and Pharmacokinetics of AN01 Inhalation Powder in Healthy Participants

Clinical trial NCT07554365 · COMPLETED

Trial details

NCT number: NCT07554365
Sponsor: AirNexis Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Healthy Participants Study

Start date: 2026-05-13
Primary completion: 2026-06-29
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.